358 related articles for article (PubMed ID: 22847027)
1. Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.
Etchin J; Sun Q; Kentsis A; Farmer A; Zhang ZC; Sanda T; Mansour MR; Barcelo C; McCauley D; Kauffman M; Shacham S; Christie AL; Kung AL; Rodig SJ; Chook YM; Look AT
Leukemia; 2013 Jan; 27(1):66-74. PubMed ID: 22847027
[TBL] [Abstract][Full Text] [Related]
2. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
Etchin J; Sanda T; Mansour MR; Kentsis A; Montero J; Le BT; Christie AL; McCauley D; Rodig SJ; Kauffman M; Shacham S; Stone R; Letai A; Kung AL; Thomas Look A
Br J Haematol; 2013 Apr; 161(1):117-27. PubMed ID: 23373539
[TBL] [Abstract][Full Text] [Related]
3. Crystallization of Nuclear Export Signals or Small-Molecule Inhibitors Bound to Nuclear Exporter CRM1.
Fung HYJ; Chook YM
Methods Mol Biol; 2022; 2502():285-297. PubMed ID: 35412246
[TBL] [Abstract][Full Text] [Related]
4. Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.
Ranganathan P; Yu X; Na C; Santhanam R; Shacham S; Kauffman M; Walker A; Klisovic R; Blum W; Caligiuri M; Croce CM; Marcucci G; Garzon R
Blood; 2012 Aug; 120(9):1765-73. PubMed ID: 22677130
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of nuclear export signal orientation in binding to exportin CRM1.
Fung HY; Fu SC; Brautigam CA; Chook YM
Elife; 2015 Sep; 4():. PubMed ID: 26349033
[TBL] [Abstract][Full Text] [Related]
7. Atomic basis of CRM1-cargo recognition, release and inhibition.
Fung HY; Chook YM
Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
[TBL] [Abstract][Full Text] [Related]
8. Correlation of CRM1-NES affinity with nuclear export activity.
Fu SC; Fung HYJ; Cağatay T; Baumhardt J; Chook YM
Mol Biol Cell; 2018 Aug; 29(17):2037-2044. PubMed ID: 29927350
[TBL] [Abstract][Full Text] [Related]
9. Novel small molecule XPO1/CRM1 inhibitors induce nuclear accumulation of TP53, phosphorylated MAPK and apoptosis in human melanoma cells.
Yang J; Bill MA; Young GS; La Perle K; Landesman Y; Shacham S; Kauffman M; Senapedis W; Kashyap T; Saint-Martin JR; Kendra K; Lesinski GB
PLoS One; 2014; 9(7):e102983. PubMed ID: 25057921
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP.
Shaikhqasem A; Schmitt K; Valerius O; Ficner R
Acta Crystallogr F Struct Biol Commun; 2021 Mar; 77(Pt 3):70-78. PubMed ID: 33682791
[TBL] [Abstract][Full Text] [Related]
11. Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals.
Fung HY; Fu SC; Chook YM
Elife; 2017 Mar; 6():. PubMed ID: 28282025
[TBL] [Abstract][Full Text] [Related]
12. Insights into the function of the CRM1 cofactor RanBP3 from the structure of its Ran-binding domain.
Langer K; Dian C; Rybin V; Müller CW; Petosa C
PLoS One; 2011 Feb; 6(2):e17011. PubMed ID: 21364925
[TBL] [Abstract][Full Text] [Related]
13. An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1.
Koyama M; Matsuura Y
EMBO J; 2010 Jun; 29(12):2002-13. PubMed ID: 20485264
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for leucine-rich nuclear export signal recognition by CRM1.
Dong X; Biswas A; Süel KE; Jackson LK; Martinez R; Gu H; Chook YM
Nature; 2009 Apr; 458(7242):1136-41. PubMed ID: 19339969
[TBL] [Abstract][Full Text] [Related]
15. Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer.
Gao J; Azmi AS; Aboukameel A; Kauffman M; Shacham S; Abou-Samra AB; Mohammad RM
Oncotarget; 2014 Jun; 5(11):3444-54. PubMed ID: 24899509
[TBL] [Abstract][Full Text] [Related]
16. A 2.1-Å-resolution crystal structure of unliganded CRM1 reveals the mechanism of autoinhibition.
Saito N; Matsuura Y
J Mol Biol; 2013 Jan; 425(2):350-64. PubMed ID: 23164569
[TBL] [Abstract][Full Text] [Related]
17. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
Niu M; Chong Y; Han Y; Liu X
Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
[TBL] [Abstract][Full Text] [Related]
18. Architecture of CRM1/Exportin1 suggests how cooperativity is achieved during formation of a nuclear export complex.
Petosa C; Schoehn G; Askjaer P; Bauer U; Moulin M; Steuerwald U; Soler-López M; Baudin F; Mattaj IW; Müller CW
Mol Cell; 2004 Dec; 16(5):761-75. PubMed ID: 15574331
[TBL] [Abstract][Full Text] [Related]
19. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
Booth DS; Cheng Y; Frankel AD
Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.
Lapalombella R; Sun Q; Williams K; Tangeman L; Jha S; Zhong Y; Goettl V; Mahoney E; Berglund C; Gupta S; Farmer A; Mani R; Johnson AJ; Lucas D; Mo X; Daelemans D; Sandanayaka V; Shechter S; McCauley D; Shacham S; Kauffman M; Chook YM; Byrd JC
Blood; 2012 Nov; 120(23):4621-34. PubMed ID: 23034282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
